Stengel W |
[Sporotrichoid mycobacteriosis caused by Mycobacterium marinum]. |
1999 |
Dtsch. Med. Wochenschr. |
pmid:10572519
|
Madsen LG et al. |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy. |
1999 |
Dig. Dis. Sci. |
pmid:10573379
|
Mach T and Zahradnik-Bilska J |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication]. |
1999 |
Prz. Lek. |
pmid:10575912
|
Dionisio D et al. |
Encephalitis caused directly by Mycoplasma pneumoniae. |
1999 |
Scand. J. Infect. Dis. |
pmid:10576133
|
Huchon G |
How to manage the low-risk patient with lower respiratory tract infection? |
1999 |
Respiration |
pmid:10577170
|
de Luis DA et al. |
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. |
1999 |
Clin Nutr |
pmid:10578022
|
Tanigawara Y et al. |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori. |
1999 |
Clin. Pharmacol. Ther. |
pmid:10579481
|
Tomioka H et al. |
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10582897
|
Komatsu H et al. |
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases. |
1999 |
Br. J. Dermatol. |
pmid:10583068
|
Semret M et al. |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler. |
1999 |
Am. J. Trop. Med. Hyg. |
pmid:10586895
|
Nasu T et al. |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains]. |
1999 |
Jpn J Antibiot |
pmid:10587879
|
Langan CE et al. |
Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. |
1999 |
J. Antimicrob. Chemother. |
pmid:10588313
|
Rodvold KA |
Clinical pharmacokinetics of clarithromycin. |
1999 |
Clin Pharmacokinet |
pmid:10589373
|
Franzin L et al. |
Clarithromycin and amoxicillin susceptibility of Helicobacter pylori strains isolated from adult patients with gastric or duodenal ulcer in Italy. |
2000 |
Curr. Microbiol. |
pmid:10594221
|
Dani R et al. |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594400
|
Harris A |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594406
|
Gomollón F et al. |
Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. |
1999 |
Helicobacter |
pmid:10597390
|
Uygun A et al. |
The effect of Helicobacter pylori eradication on duodenal gastric metaplasia. |
1999 Jul-Aug |
J. Int. Med. Res. |
pmid:10599027
|
Auclair B et al. |
Potential interaction between itraconazole and clarithromycin. |
1999 |
Pharmacotherapy |
pmid:10600094
|
Feldman M et al. |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. |
1999 |
Am. J. Physiol. |
pmid:10600812
|